Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

Related Keywords

China ,Suzhou ,Jiangsu , ,Prnewswire Kintor Pharmaceutical Limited Pharma ,Pharmaceutical Limited ,Kintor Pharma ,